Market Price

70.40 

-0.20 -0.3%

as of Jan 16 '19

52 Week Range:

60.42 75.11


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients. The Agilent CrossLab segment offers GC and LC columns, sample preparation products, custom chemistries, and various laboratory instrument supplies; and startup, operational, training, compliance support, and software as a service, as well as asset management and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was founded in 1999 and is headquartered in Santa Clara, California.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Oct '08 Oct '09 Oct '10 Oct '11 Oct '12 Oct '13 Oct '14 Oct '15 Oct '16 Oct '17 Oct '18
Equity (BVPS) 7.31
7.19
8.10
12.41
14.98
14.38
16.83
12.36
13.40
14.31
14.35
growth rate -1.6% 12.7% 53.2% 20.7% -4.0% 17.0% -26.6% 8.4% 6.8% 0.3%
Earnings BIT 815.00
7.00
692.00
1,030.00
1,040.00
859.00
419.00
525.00
698.00
883.00
928.00
growth rate -99.1% 9,785.7% 48.8% 1.0% -17.4% -51.2% 25.3% 33.0% 26.5% 5.1%
Avg.PE 11.86
-224.00
17.95
13.00
11.01
24.21
28.15
35.12
33.00
32.07
74.77
growth rate -100.0% 100.0% -27.6% -15.3% 119.9% 16.3% 24.8% -6.0% -2.8% 133.2%
ROA 9.25
-0.41
7.90
10.79
11.77
6.82
4.68
4.38
6.05
8.43
3.72
growth rate -100.0% 100.0% 36.6% 9.1% -42.1% -31.4% -6.4% 38.1% 39.3% -55.9%
ROE 23.93
-1.22
23.86
26.86
24.30
13.83
9.52
8.47
10.99
15.08
6.72
growth rate -100.0% 100.0% 12.6% -9.5% -43.1% -31.2% -11.0% 29.8% 37.2% -55.4%
ROIC 13.85
0.15
10.98
16.14
17.59
10.58
7.29
6.55
8.58
11.09
5.05
growth rate -98.9% 7,220.0% 47.0% 9.0% -39.9% -31.1% -10.2% 31.0% 29.3% -54.5%
Cur. Ratio 2.42
3.53
2.00
3.03
2.45
3.11
3.23
3.78
3.85
3.30
3.29
growth rate 45.9% -43.3% 51.5% -19.1% 26.9% 3.9% 17.0% 1.9% -14.3% -0.3%
Quick Ratio 1.66
2.75
1.14
2.39
1.73
2.23
2.36
2.67
3.09
2.69
2.58
growth rate 65.7% -58.6% 109.7% -27.6% 28.9% 5.8% 13.1% 15.7% -12.9% -4.1%
Leverage 2.91
3.04
3.00
2.10
2.03
2.02
2.04
1.79
1.84
1.74
1.87
growth rate 4.5% -1.3% -30.0% -3.3% -0.5% 1.0% -12.3% 2.8% -5.4% 7.5%
Balance Sheet Oct '08 Oct '09 Oct '10 Oct '11 Oct '12 Oct '13 Oct '14 Oct '15 Oct '16 Oct '17 Oct '18
Acct.Receivable 770.00
595.00
869.00
860.00
923.00
899.00
708.00
710.00
714.00
801.00
776.00
growth rate -22.7% 46.1% -1.0% 7.3% -2.6% -21.3% 0.3% 0.6% 12.2% -3.1%
Acct.Payable 1,195.00
1,223.00
1,163.00
302.00
279.00
257.00
305.00
340.00
growth rate 2.3% -4.9% -74.0% -7.6% -7.9% 18.7% 11.5%
Cur.Assets 3,182.00
3,961.00
6,169.00
5,569.00
4,629.00
4,983.00
5,509.00
3,686.00
3,635.00
4,169.00
3,848.00
growth rate 24.5% 55.7% -9.7% -16.9% 7.7% 10.6% -33.1% -1.4% 14.7% -7.7%
Total Assets 7,007.00
7,612.00
9,696.00
9,057.00
10,536.00
10,686.00
10,815.00
7,479.00
7,794.00
8,426.00
8,541.00
growth rate 8.6% 27.4% -6.6% 16.3% 1.4% 1.2% -30.9% 4.2% 8.1% 1.4%
Cash 1,405.00
2,479.00
2,649.00
3,527.00
2,351.00
2,675.00
2,218.00
2,003.00
2,289.00
2,678.00
2,247.00
growth rate 76.4% 6.9% 33.1% -33.3% 13.8% -17.1% -9.7% 14.3% 17.0% -16.1%
Inventory 646.00
552.00
716.00
898.00
1,014.00
1,066.00
574.00
541.00
533.00
575.00
638.00
growth rate -14.6% 29.7% 25.4% 12.9% 5.1% -46.2% -5.8% -1.5% 7.9% 11.0%
Cur.Liabilities 1,330.00
1,123.00
3,083.00
1,837.00
1,893.00
1,602.00
1,692.00
976.00
945.00
1,263.00
1,171.00
growth rate -15.6% 174.5% -40.4% 3.1% -15.4% 5.6% -42.3% -3.2% 33.7% -7.3%
Liabilities 4,448.00
5,106.00
6,468.00
4,749.00
5,354.00
5,400.00
5,511.00
3,309.00
3,548.00
3,591.00
3,970.00
growth rate 14.8% 26.7% -26.6% 12.7% 0.9% 2.1% -40.0% 7.2% 1.2% 10.6%
LT Debt 2,125.00
2,904.00
2,190.00
1,932.00
2,112.00
2,699.00
1,663.00
1,655.00
1,904.00
1,801.00
1,799.00
growth rate 36.7% -24.6% -11.8% 9.3% 27.8% -38.4% -0.5% 15.1% -5.4% -0.1%
Equity 2,559.00
2,506.00
3,228.00
4,308.00
5,182.00
5,286.00
5,301.00
4,167.00
4,243.00
4,831.00
4,567.00
growth rate -2.1% 28.8% 33.5% 20.3% 2.0% 0.3% -21.4% 1.8% 13.9% -5.5%
Common Shares 371.00
346.00
353.00
355.00
353.00
345.00
338.00
335.00
329.00
326.00
325.00
growth rate -6.7% 2.0% 0.6% -0.6% -2.3% -2.0% -0.9% -1.8% -0.9% -0.3%
Cash Flow Statement Oct '08 Oct '09 Oct '10 Oct '11 Oct '12 Oct '13 Oct '14 Oct '15 Oct '16 Oct '17 Oct '18
Capital Expenditures 140.00
127.00
114.00
188.00
194.00
195.00
205.00
98.00
139.00
176.00
177.00
growth rate -9.3% -10.2% 64.9% 3.2% 0.5% 5.1% -52.2% 41.8% 26.6% 0.6%
Cash Dividends 0.00
0.00
0.00
0.00
104.00
156.00
176.00
133.00
150.00
170.00
191.00
growth rate 50.0% 12.8% -24.4% 12.8% 13.3% 12.4%
Cash From OA 756.00
408.00
718.00
1,260.00
1,228.00
1,152.00
731.00
1,322.00
793.00
889.00
1,087.00
growth rate -46.0% 76.0% 75.5% -2.5% -6.2% -36.6% 80.9% -40.0% 12.1% 22.3%
FCF per Share 1.62
0.89
1.26
3.02
2.93
2.96
2.16
0.90
2.02
2.04
2.46
growth rate -45.1% 41.6% 139.7% -3.0% 1.0% -27.0% -58.3% 124.4% 1.0% 20.6%
Sale Purchase of Stock -193.00
-78.00
-742.00
188.00
58.00
62.00
66.00
growth rate 0.0% 0.0% 100.0% -69.2% 6.9% 6.5%
FCF 602.00
280.00
597.00
1,072.00
1,034.00
957.00
506.00
393.00
654.00
713.00
910.00
growth rate -53.5% 113.2% 79.6% -3.5% -7.5% -47.1% -22.3% 66.4% 9.0% 27.6%
Income Statement Oct '08 Oct '09 Oct '10 Oct '11 Oct '12 Oct '13 Oct '14 Oct '15 Oct '16 Oct '17 Oct '18
Sales 5,774.00
4,481.00
5,444.00
6,615.00
6,858.00
3,894.00
4,048.00
4,038.00
4,202.00
4,472.00
4,914.00
growth rate -22.4% 21.5% 21.5% 3.7% -43.2% 4.0% -0.3% 4.1% 6.4% 9.9%
Op.Income 795.00
47.00
566.00
1,012.00
1,153.00
225.00
419.00
525.00
698.00
883.00
928.00
growth rate -94.1% 1,104.3% 78.8% 13.9% -80.5% 86.2% 25.3% 33.0% 26.5% 5.1%
IBT 815.00
7.00
692.00
1,032.00
1,043.00
293.00
229.00
480.00
544.00
803.00
946.00
growth rate -99.1% 9,785.7% 49.1% 1.1% -71.9% -21.8% 109.6% 13.3% 47.6% 17.8%
Net Income 693.00
-31.00
684.00
1,012.00
1,153.00
225.00
549.00
401.00
462.00
684.00
316.00
growth rate -100.0% 100.0% 48.0% 13.9% -80.5% 144.0% -27.0% 15.2% 48.1% -53.8%
EPS 1.87
-0.09
1.94
2.85
3.27
2.13
1.62
1.20
1.40
2.10
0.97
growth rate -100.0% 100.0% 46.9% 14.7% -34.9% -23.9% -25.9% 16.7% 50.0% -53.8%
Gross Profit 3,196.00
2,292.00
2,930.00
3,529.00
3,604.00
1,907.00
1,976.00
2,041.00
2,197.00
2,409.00
2,687.00
growth rate -28.3% 27.8% 20.4% 2.1% -47.1% 3.6% 3.3% 7.6% 9.7% 11.5%
R&D 704.00
642.00
612.00
649.00
668.00
337.00
358.00
327.00
325.00
339.00
385.00
growth rate -8.8% -4.7% 6.1% 2.9% -49.6% 6.2% -8.7% -0.6% 4.3% 13.6%

Quarterly Statements

Item Name Oct '17 Jan '18 Apr '18 Jul '18 Oct '18
Earnings BIT 270.00
239.00
220.00
237.00
249.00
growth rate -11.5% -8.0% 7.7% 5.1%
Balance Sheet Oct '17 Jan '18 Apr '18 Jul '18 Oct '18
Acct.Receivable 801.00
751.00
754.00
733.00
776.00
growth rate -6.2% 0.4% -2.8% 5.9%
Acct.Payable 305.00
292.00
271.00
273.00
340.00
growth rate -4.3% -7.2% 0.7% 24.5%
Cur.Assets 4,169.00
4,397.00
4,525.00
3,667.00
3,848.00
growth rate 5.5% 2.9% -19.0% 4.9%
Total Assets 8,426.00
8,698.00
8,784.00
8,349.00
8,541.00
growth rate 3.2% 1.0% -5.0% 2.3%
Cash 2,678.00
2,887.00
3,011.00
2,131.00
2,247.00
growth rate 7.8% 4.3% -29.2% 5.4%
Inventory 575.00
608.00
594.00
623.00
638.00
growth rate 5.7% -2.3% 4.9% 2.4%
Cur.Liabilities 1,263.00
1,361.00
1,365.00
1,014.00
1,171.00
growth rate 7.8% 0.3% -25.7% 15.5%
Liabilities 3,591.00
4,172.00
4,167.00
3,781.00
3,970.00
growth rate 16.2% -0.1% -9.3% 5.0%
LT Debt 1,801.00
1,800.00
1,800.00
1,799.00
1,799.00
growth rate -0.1% 0.0% -0.1% 0.0%
Equity 4,831.00
4,522.00
4,613.00
4,564.00
4,567.00
growth rate -6.4% 2.0% -1.1% 0.1%
Common Shares 3.00
3.00
3.00
3.00
3.00
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Oct '17 Jan '18 Apr '18 Jul '18 Oct '18
Capital Expenditures 58.00
60.00
48.00
33.00
36.00
growth rate 3.5% -20.0% -31.3% 9.1%
Cash Dividends 43.00
48.00
48.00
48.00
47.00
growth rate 11.6% 0.0% 0.0% -2.1%
Cash From OA 288.00
215.00
303.00
197.00
372.00
growth rate -25.4% 40.9% -35.0% 88.8%
Sale Purchase of Stock 8.00
25.00
11.00
growth rate 212.5% -56.0%
FCF 230.00
155.00
255.00
164.00
336.00
growth rate -32.6% 64.5% -35.7% 104.9%
Income Statement Oct '17 Jan '18 Apr '18 Jul '18 Oct '18
Sales 1,189.00
1,211.00
1,206.00
1,203.00
1,294.00
growth rate 1.9% -0.4% -0.3% 7.6%
Op.Income 270.00
239.00
220.00
237.00
249.00
growth rate -11.5% -8.0% 7.7% 5.1%
IBT 226.00
233.00
227.00
242.00
244.00
growth rate 3.1% -2.6% 6.6% 0.8%
Net Income 177.00
-320.00
205.00
236.00
195.00
growth rate -100.0% 100.0% 15.1% -17.4%
EPS
growth rate
Gross Profit 647.00
673.00
644.00
661.00
709.00
growth rate 4.0% -4.3% 2.6% 7.3%
R&D 89.00
93.00
91.00
97.00
104.00
growth rate 4.5% -2.2% 6.6% 7.2%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

E (19.34)

YOY Growth Grade:

E (29.04)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 72.56 72.58 20.82
EPS / Growth -5.1% 0.97 10.7%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 1.1%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 1.1% 1.1%
Future PE 2.00 11.46 11.46
Future EPS 1.07 1.08 1.08
Value Price
MOS %
0.53
-99.2%
3.05
-95.7%
3.05
-95.7%
MOS Price 0.26 1.53 1.53
IRT 54.42 53.80 53.80

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.